420 with CNW – Illinois Governor Signs Two Bills Expanding Medical Marijuana Program

As another sign of his pledge to make marijuana accessible to Illinois residents, Gov. J.B. Pritzker signed two more bills on Monday expanding the medical marijuana program of the state. He stated that the signing ceremony was a message to all medical marijuana users in the state that the state government was on their side.

Senate Bill 2023 was intended to make the medical marijuana program permanent in Illinois. Under the law which legalized medical marijuana back in 2013, the program was transitional and had been given a lifespan of four years.

This particular bill also added 11 conditions to the list of qualifying conditions for which patients can get a recommendation from a doctor to use medical marijuana. The additional conditions include migraines, irritable bowel syndrome, chronic pain, polycystic kidney disease and several other conditions.

Starting in January next year, patients on the medical marijuana program will also be allowed to grow a maximum of five cannabis plants. These plants should be in locked areas that are far from public view.

As soon as Senate Bill 2023 was signed, physicians’ assistants and nurse practitioners were allowed to start certifying patients who wished to enroll on the medical marijuana program.

Senate Bill 455 was also signed on Monday. Under this law, kids who are registered to use medical cannabis can now starting getting their treatment on school premises as long as the administration of the medical marijuana is supervised by a member of staff at the school.

The bill also emphasizes that no one who hasn’t attained the age of 21 will be allowed to legally buy marijuana that can be smoked.

The medical marijuana program has seen many modifications from the original program of 2013 which was variously described as too restrictive. For example, under that law, patients had to get a written recommendation from a doctor before being certified to use medical marijuana and they could only buy 2.5 ounces every fortnight. The patients also had to make a pledge that they would never use medical marijuana in the presence of kids or in public. The number of qualifying conditions was also smaller, but most of these restrictions have gradually been eased.

Additionally, the state instituted an Opioid Alternative Pilot Program in February. Under this program, Illinois residents who have opioid abuse problems can have an accelerated path to temporary access to medical cannabis.

As the country counts down to next year when recreational marijuana will become available to residents, experts believe that marijuana industry participants like Golden Developing Solutions Inc. (OTC: DVLP) and Grapefruit Boulevard Investments Inc. (OTCQB: IGNG) are pleased by the progressive way in which matters of the cannabis industry are being handled in Illinois.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Colorado Lawmakers Pass Bill Allowing Medical Marijuana as Alternative to Opioids

Across the U.S., more than 130 people die each day due to overdosing on opioids. Colorado has permitted medical marijuana to be used as a way to combat this crisis, at least within its borders. This makes Colorado the third state in the country to give doctors permission to discuss medical marijuana with their patients who need opioids to deal with their acute or post-operative pain.

The other states that have this provision are Illinois and New York. Two other states (New Jersey and Pennsylvania) have allowed patients diagnosed with opioid use disorder to consider medical marijuana as a treatment option.

Rep. Edie Hooton, the Colorado lawmaker who co-sponsored the bill to legalize the use of medical marijuana as an alternative to opioids, said that the law was designed to give doctors the legal protection that they needed in order to discuss medical marijuana freely with their patients. He added that the passing of the bill on Friday now makes it normal for doctors to have this conversation.

While the supporters of this new law say that it will help to curb the opioid crisis in the state, there is insufficient scientific research to support this assertion. One of the studies which is cited to prove that medical marijuana can curb the opioid crisis is a study which was published in JAMA in 2014.

That research found that there was a 25 percent drop in the number of people dying from opioid overdoses in the states where medical marijuana is legal. The data analyzed covered the years between 1999 and 2010.

However, other studies done on the subject have come up with opposite conclusions, with a recent study which expanded the timeframe to 2017 revealing that opioid overdoses increased by almost 23 percent in the states with legal medical marijuana.

As the scientific community works round the clock to build consensus on how useful medical marijuana may be in stemming the tide of deaths associated with opioids, state lawmakers have gone ahead to enact policies and laws permitting the use of marijuana as an alternative to prescription meds for pain. These lawmakers believe that giving patients more options will empower them to choose what they believe will work for them instead of being forced to use opioids, thereby exposing themselves to the well-documented harmful side effects of these drugs.

For example, the state of Illinois launched its Opioid Alternative Pilot Program in January this year in order to gather data on how patients manage their pain if they are allowed to use medical marijuana instead of opioids. So far, 2,000 patients have signed up.

The entire cannabis industry believes that industry players, such as Geyser Brands Inc. (TSX.V: GYSR) and Golden Developing Solutions Inc. (OTC: DVLP), hope that the patient data collected will provide proof that medical marijuana can play a part in taming the opioid crisis.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Bipartisan Senate Bill Seeks to Ease Marijuana Business Access to Insurance Services

A bipartisan bill introduced in the U.S. Senate on Monday seeks to ensure greater access to insurance policies for marijuana businesses in states where the drug is legal. The bill titled “Clarifying Law Around Insurance of Marijuana (CLAIM) Act” was sponsored by Sen. Bob Menendez (D-NJ). The cosponsors of the legislation are Sens. Jeff Merkley (D-OR), Rand Paul (R-KY) and Kevin Cramer (R-ND).

Currently, federal law makes it very difficult for cannabis businesses to get casualty, property and title insurance cover regardless of the state laws on the matter.

If the CLAIM Act is passed, insurance companies wouldn’t have to fear that they would be penalized or discouraged from selling insurance policies to companies that directly or indirectly serve the marijuana industry. For example, federal punitive action wouldn’t be taken against an insurer who covers the property managers hired by marijuana businesses.

Additionally, the law would bar federal agencies from incentivizing, encouraging or recommending that insurance companies refrain from working normally with a business in the marijuana industry or one indirectly serving the industry.

The draft law also includes protections for people who are employed by insurance companies. Its provisions free these people from being held liable for the work that they do when serving marijuana businesses.

While introducing the bill, Menendez said that marijuana businesses are unable to protect their customers, employees, premises and other property. The bill would therefore correct this situation and put cannabis businesses at par with businesses in other industries.

Sen. Rand Paul added to what Menendez said by saying that the basic principles behind the CLAIM Act are that the federal government should respect what the people in many states have decided and put an end to the barriers legitimate businesses are facing regarding access to basic protections.

The supporters of this bill assert that giving cannabis companies access to insurance cover would also remove some barriers to financing since many lending institutions automatically disqualify businesses that cannot get insurance cover.

While supporting this legislation, the media relations director of NCIA (national cannabis industry association) said that the wildfires in California and other cannabis growing regions had shown that the long-term survival of the marijuana industry depends on their ability to get insurance cover against all the foreseeable risks, just like other businesses do.

Gov. Phil Murphy (D) of New Jersey, who recently signed a law expanding the medical marijuana program of the state, also supported the bill introduced by Menendez. Murphy said it was important that medical marijuana providers are given the same protections that are the norm for the providers of other medical services.

Analysts are waiting to hear what the different marijuana businesses, such as Grapefruit Boulevard Investments Inc. (OTCQB: IGNG) and Golden Developing Solutions Inc. (OTC: DVLP), have to say about the flurry of activity regarding marijuana policy reform in both legislative chambers of the U.S.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Can the Pechoti Method Apply to Weed as Well?

Pecho…what? If you are hearing about the Pechoti method for the first time, you aren’t alone, although this mode of administration of alternative remedies isn’t new. It entails putting drops of essential oils on the belly button as a way of treating different conditions, including PMS, nausea and pain. Now some people have been suggesting that one can ingest cannabis oil in this way. But is this even possible?

What the Pechoti Method Is

As mentioned earlier, the Pechoti method refers to an old Ayurveda treatment method in which essential oils are dropped onto the belly button to combat different conditions.

The Pechoti method derives its name from the Pechoti gland which is said to exist right behind the belly button. This gland remains in existence even if an infant’s umbilical cord is cut, and the gland remains throughout one’s life, according to the believers in this method of treatment.

The advocates of this method reason that once a human is formed in the womb, all the nutrition goes through the umbilical cord until the baby is born. They argue that if a baby could entirely depend on what is coming through the umbilical cord, why shouldn’t an adult continue using this vital part?

How It Works

Doctors who believe in this treatment method, like Dr. Lakisha Jenkins, say that approximately 72,000 veins pass through the umbilical cord and continue to all parts of the body. This means that any oil that is placed on the belly button is eventually absorbed and circulated throughout the body.

Dr. Jenkins adds that the gastrointestinal tract contains multiple cannabinoid receptors. The gut also plays a critical role in our immune system as well as the central nervous system. When cannabis oil is applied to the belly button, it navigates its way to the whole body through the veins that pass through the belly button.

Who Should Use this Method?

Proponents of the Pechoti method say that it works in the same way as suppositories since both are systemic (work on the whole body rather than the small part where they are applied). Since the cannabis oil administered in this way isn’t metabolized in the liver, a user cannot get high.

Consequently, kids and people who are so ill that they cannot smoke marijuana or ingest it orally can benefit from the Pechoti method.

People with endocrine system disorders, nervous system problems, gastrointestinal issues and those with neurological complaints are some of the people who can try using the Pechoti method to administer their cannabis oil treatment.

However, the effectiveness of the Pechoti method for using cannabis oil is subject to one condition; one must use organic oil from a trusted source so that the risk of impurities entering your bloodstream is avoided.

Analysts believe that the cannabis industry players like Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) and Golden Developing Solutions Inc. (OTC: DVLP), must be amazed at how creative people have become in coming up with different ways to ingest cannabis.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Cannabis Companies Seek Strong Strategies to Meet Growing Demand

CannabisNewsWire Editorial Coverage: With demand outstripping supply, successful cannabis companies are following smart core strategies and reporting strong revenues.

Golden Developing Solutions Inc. (OTC: DVLP) (DVLP Profile) has used a mix of acquisitions, diverse brands and products, and increased production footprint to meet customer demand and report significant revenue increases, including its strongest second-quarter numbers ever. Industry giant Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) has followed a similar path, though some change may follow the recent departure of its co-CEO. Tilray Inc. (NASDAQ: TLRY) has invested heavily in increasing production while reaching into new markets such as the United Kingdom. Medmen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) and Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) have both shown the potential for growing…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – 4 Ways to Spot the Best CBD Products

The exploding popularity of CBD as a health and wellness product in a largely unregulated market (so far) creates a need for each buyer to vigilant when deciding where to spend their hard-earned money on CBD products. Here are some tips that can help you to sort the great products from those that may not be so great.

Buy from Licensed Dispensaries/Brands

There’s a reason why McDonalds, Starbucks and other major brands attract thousands to their doors each day; buyers are sure that the products they purchase will be of the same quality that they have learned to expect. Similarly, known brands in the cannabis space, such as Golden Developing Solutions Inc. (OTC: DVLP) and Geyser Brands Inc. (TSX.V: GYSR), go to great lengths to provide high-quality products. Consequently, you stand a high chance of getting the best CBD products if you shop from such establishments when compared to another person who takes their chance with any random supplier online or offline.

Scrutinize Online Reviews

Product sellers know that the opinions of buyers matter when potential customers are making a buying decision. Some sellers will therefore do everything they can to tip buyer opinions in their favor, including writing fake reviews. It is therefore helpful for you to read through the product reviews with a critical eye. Do you see many reviews posted at approximately the same time? Are the names or photos of the people who posted those reviews questionable? These may be pointers that the reviews aren’t authentic, so be wary of buying that product. You can also go a step further and use an online tool that ranks sites on how genuine their product reviews are so that you are sure that the reviews upon which you make your buying decision are genuine.

Compare Product Prices

The CBD industry is relatively new, so most manufacturers use the same methods to extract and package products. This means that there shouldn’t be a big variation in the price of comparable products. If a certain product has a price which is significantly lower than the price charged by other sellers, investigate further to ascertain the authenticity of that product. Beware of products whose price seems too good to be true!

Analyze the Product Benefits on the Packaging

While there is still limited scientific research about the health and wellness of benefits of marijuana and its derivatives like CBD, the benefits listed on the packaging shouldn’t be too outlandish either. For example, how will you know that a given product has provided “emotional cleansing” as the package claims? Do your research and only buy products whose stated benefits are realistic given the available information on the subject.

There are indications that the FDA will draft rules to regulate CBD products which are added to food and drinks, and individual states are also drafting their own rules. Until these come in force, the tips above will go a long way in ensuring that you buy the best CBD products available.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – CBD Shows Promise in Study on Superbugs

As bugs get more resistant to the existing antibiotics, researchers are looking for new ways to combat infections and cannabidiol, a marijuana compound, is showing promise as a remedy for superbugs.

A new study conducted by researchers in Brisbane, Australia has shown that CBD has promising antimicrobial activity against some strains of Gram-positive bacteria, such as varieties of strep and staph bacteria.

In the study, a synthetic form of CBD was placed in lab dishes containing the bugs being investigated. The cannabis compound showed the same level of antimicrobial activity as two existing prescription antibiotics (daptomycin and vancomycin). The synthetic CBD even went as far as killing some strains of strep and staph bacteria that no longer responded to the two prescription antibiotics.

Additionally, the synthetic compound also acted against bacterial biofilms. These biofilms are formed when proteins are secreted by bacteria on surfaces. Such surfaces can become slippery, and the resulted infections are very difficult to treat. The in vitro tests showed that CBD can combat such biofilms.

The researchers have cautioned that people should not start treating themselves against infections using CBD since this research was an in vitro (in test tubes) study and the findings aren’t a guarantee that similar results will be observed in humans.

Mark Blaskovich, the lead author of the study, said that people are better off sticking to the current treatment options against infections until such a time when their preliminary research findings are pursued further and confirm that CBD works effectively to fight infections in humans.

The study was conducted as a collaboration between Botanix Pharmaceuticals (a drug discovery company) and the Center for Superbug Solutions at the University of Queensland in Brisbane, Australia.

While the research is yet to be published in a peer-reviewed journal, it was presented on June 23 to the American Society for Microbiology during its annual meeting in San Francisco.

It is still early days before CBD is developed into a drug for infections. As already mentioned, further research is needed to establish at what dosage CBD can combat infections in humans, how best to administer the compound for maximum effect, and what side effects, if any, may result from the use of CBD as an antibiotic at the therapeutic dosage established.

The authors of this study are now set on conducting animal studies on the antibacterial activity of CBD while Botanix Pharmaceuticals has set its sights on studying whether CBD can be used to kill staph bacteria on the skin of people before they undergo surgery. This step is essential in preventing post-surgical infections.

Industry watchers expect the entire cannabis industry, including players like Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) and Golden Developing Solutions Inc. (OTC: DVLP), to feel vindicated by the proof emerging about the health benefits of different marijuana compounds.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Colorado Hits the $1 Billion Cannabis State Revenue Mark

The state of Colorado has now pocketed more than $1 billion in revenue from the legal cannabis industry. This marks yet another milestone for the state which legalized marijuana in 2014.

According to marijuana sales data which has just been released by the state, cannabis sales hit the $6.5 billion mark at the end of May this year. The data also shows that the sales of recreational marijuana are continuing to rise higher as the months roll by.

April and May 2019 have also been the best months so far in the entire history of the cannabis industry in Colorado with the monthly state revenue reaching the highest level ever at $24.2 million in April. The state took approximately three and a half years to reach cannabis sales totaling $500 million, but the state was able to double that figure in less than two years to cross the $1 billion mark.

Since July 2017, the revenue collected by the state from the cannabis industry has never gone below $20 million each month. This shows massive growth given that the total state revenue from marijuana in February 2014 was just $3.5 million.

Speaking at a Net Net event in Denver on May 1, Gov. Polis revealed that the marijuana industry was doing very well because it had created “tens of thousands of jobs, reducing crime, filling up buildings and bringing state revenue.”

Speaking of creating jobs, there are 41,076 people who have licenses to work in the Colorado cannabis industry. It is reasonable to conclude that nearly all those people are indeed employed in the industry since the licenses are renewed every two years and it wouldn’t make sense for someone to pay for and renew a license if they aren’t working in the industry.

Gov. Polis wants to see the cannabis industry take even bigger strides and take full advantage of its trailblazer status across the country. He knows that cannabis sales will never equal those in bigger states, such as New Jersey and California, so he has set his sights on other ways through which Colorado can remain a leader in the industry. For example, he wants to see cannabis point of sale systems, cannabis genetics and cannabis chemistry innovations headquartered in Colorado from where other states are served by those companies.

With sales and state revenues hitting such highs, who would blame the governor for dreaming big? The situation in Colorado is far different from other states, such as California, where the legal cannabis industry is struggling under the yoke of high taxes, a vibrant black market and legal battles with local authorities and cities which have banned marijuana sales in their jurisdictions.

If only one could be a fly on the wall and hear what goes on in the corridors of companies like Golden Developing Solutions Inc. (OTC: DVLP) and Geyser Brands Inc. (TSX.V: GYSR) as they talk about the contrast between what is happening in Colorado and in California!

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Georgia Governor Signs Cannabis Oil Bill

Gov. Brian kemp has signed a bill that will make it possible for licensed entities to produce and distribute oils and other products which have limited amounts of plant-derived THC.

House Bill 324 also lays the ground for the establishment of a commission to regulate and oversee the production, manufacture and dispensing of products having the specified amounts of THC to patients who have been registered to receive those products.

Under the bill which has now been signed into law, the state will cooperate with Georgia University to manufacture THC-infused extracts and oils. A maximum of six cultivators will be licensed to operate within the state, according to the new law.

Medical marijuana was legalized in Georgia in 2015. However, the law which legalized this form of medicine didn’t establish mechanisms through which qualifying patients could access low-THC cannabis oils and extracts.

The latest law is intended to fix that shortcoming so that patients can access state-regulated cannabis oils and extracts instead of merely taking comfort in a law which allows them to use these products yet no system is in place to avail the permitted products.

Currently, about 9,500 patients have been approved to use medical cannabis oil. The law sets a possession limit of 20 fluid announces of medical cannabis oil whose THC concentration doesn’t exceed 5 percent.

A registry card issued by the Georgia Department of Public Health protects members of the public from being arrested and prosecuted for possessing a controlled substance.

The state has a small number of patients on its medical marijuana program because Georgia enacted a highly restrictive medical marijuana law.

Under the law, medical marijuana cannot be used in leaf or edible form as is the case in nearly all other jurisdictions where medical marijuana is legal. Vaporization of cannabis oil is also banned in the state.

Additionally, Georgia doesn’t give physicians the right to prescribe cannabis oil to patients. Instead, the physician simply fills a patient certification form confirming that the patient has one of the 17 qualifying conditions, and then the physician and the patient sign a waiver form before the patient certification form is mailed to the Department of Public Health for consideration.

It remains to be seen whether the enactment of the law facilitating the manufacture and sale of cannabis oil will result in an increase in the number of people who apply for the Low THC Oil Registry Card.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) and Golden Developing Solutions Inc. (OTC: DVLP) hope that Georgia will enact other reforms soon so that its medical cannabis program expands to the level that other states have reached.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Massachusetts Regulators Vote on Cannabis Home Delivery

Marijuana regulators have reached an agreement about plans to allow the home delivery of marijuana products within the state. A vote of 4-1 was passed by the Cannabis Control Commission.

If the plan gets final approval from the commission by the end of May, the delivery of cannabis products within the state would mainly be done by people from the communities that suffered the most during the War on Drugs.

The rules pave the way for people from those disadvantaged communities to have an expedited entry into the legal cannabis industry. Under the regulatory policies, home delivery licenses would exclusively be given to people from communities which were disproportionately targeted during the enforcement of prohibitionist marijuana laws.

The program will run for 24 months after which the regulators will assess its performance before deciding whether to extend it or open the space for all who are interested to apply for licenses.

Companies that are granted home delivery licenses will be free to work for as many cannabis retailers as they can take on, but the delivery vehicles will be obliged to return to the retailer any cannabis products which aren’t sold by the end of the day.

The law by which recreational marijuana was legalized in the state stipulated that a diversity program must be implemented in order to give more people a chance to benefit from the legal marijuana industry.

The home delivery system is therefore seen as one of the ways through which broader participation in the industry can be facilitated.

Regulators hope that the target population will take advantage of the exclusivity period in order to participate in the cannabis industry because the requirements for one to get a home delivery license aren’t as stringent as those for one who wants to get a marijuana cultivation or processing license.

For example, it is harder to access the capital needed to set up a processing plant, but one can find it easier to get funds to establish a cannabis home delivery business.

Kay Doyle, one of the members of the Cannabis Control Commission, expressed concerns that the desired results may not be realized within the initial 24 months, so it was a good thing to include a provision stating that once those months elapse, a review would be conducted before a decision is made regarding the future of the empowerment program.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) and Golden Developing Solutions Inc. (OTC: DVLP) look forward to the time when the social equity and empowerment programs bring the people targeted into the mainstream marijuana industry.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com